Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
183 | 3 | NOONAN SYNDROME//PTEN//CELL BIOLOGY | 56293 |
1016 | 2 | PTEN//MTOR//PI3K | 10616 |
1321 | 1 | MTOR//RAPAMYCIN//MTORC2 | 2732 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | MTOR | authKW | 938953 | 21% | 14% | 571 |
2 | RAPAMYCIN | authKW | 525609 | 13% | 13% | 345 |
3 | MTORC2 | authKW | 357502 | 2% | 50% | 62 |
4 | RHEB | authKW | 295631 | 2% | 47% | 55 |
5 | RICTOR | authKW | 294979 | 2% | 47% | 54 |
6 | MTORC1 | authKW | 284266 | 4% | 23% | 108 |
7 | CCI 779 | authKW | 277099 | 1% | 78% | 31 |
8 | RAD001 | authKW | 259139 | 2% | 42% | 53 |
9 | MTOR INHIBITOR | authKW | 174963 | 4% | 16% | 96 |
10 | TEMSIROLIMUS | authKW | 169274 | 3% | 20% | 72 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Oncology | 12563 | 36% | 0% | 981 |
2 | Cell Biology | 9248 | 31% | 0% | 834 |
3 | Biochemistry & Molecular Biology | 3399 | 32% | 0% | 862 |
4 | Hematology | 457 | 5% | 0% | 129 |
5 | Genetics & Heredity | 196 | 5% | 0% | 136 |
6 | Chemistry, Medicinal | 143 | 3% | 0% | 80 |
7 | Developmental Biology | 137 | 2% | 0% | 49 |
8 | Pharmacology & Pharmacy | 131 | 7% | 0% | 185 |
9 | Endocrinology & Metabolism | 109 | 4% | 0% | 102 |
10 | Medicine, Research & Experimental | 106 | 4% | 0% | 98 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | SIGNAL TRANSDUCT CANC METAB | 34603 | 0% | 100% | 3 |
2 | SERV MED INTERNE UF HEMATOL | 32035 | 0% | 56% | 5 |
3 | DIPARTIMENTO SCI ANAT UMANE | 26361 | 0% | 57% | 4 |
4 | CLIN COLORECTAL TUMOR | 23069 | 0% | 100% | 2 |
5 | SECT MOL ONCOL LUNG CANC | 23069 | 0% | 100% | 2 |
6 | SPECT SUPPORT IL | 23069 | 0% | 100% | 2 |
7 | GENET COMPLEX DIS | 16800 | 1% | 5% | 27 |
8 | HENRY SINGLETON BRAIN TUMOR PROGRAM | 16772 | 0% | 36% | 4 |
9 | TOXICOL INSPECT | 15378 | 0% | 67% | 2 |
10 | TRANSDUCC SENALES CANC | 15378 | 0% | 67% | 2 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | MOLECULAR CANCER THERAPEUTICS | 3305 | 1% | 1% | 35 |
2 | MOLECULAR CELL | 3196 | 1% | 1% | 40 |
3 | CLINICAL CANCER RESEARCH | 2895 | 2% | 0% | 63 |
4 | CELL METABOLISM | 2892 | 1% | 1% | 20 |
5 | ONCOTARGET | 2451 | 2% | 0% | 60 |
6 | CELLULAR SIGNALLING | 2410 | 1% | 1% | 31 |
7 | JOURNAL OF BIOLOGICAL CHEMISTRY | 1871 | 6% | 0% | 167 |
8 | SCIENCE SIGNALING | 1813 | 1% | 1% | 16 |
9 | CURRENT CANCER DRUG TARGETS | 1632 | 0% | 1% | 12 |
10 | TARGETED ONCOLOGY | 1625 | 0% | 2% | 8 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MTOR | 938953 | 21% | 14% | 571 | Search MTOR | Search MTOR |
2 | RAPAMYCIN | 525609 | 13% | 13% | 345 | Search RAPAMYCIN | Search RAPAMYCIN |
3 | MTORC2 | 357502 | 2% | 50% | 62 | Search MTORC2 | Search MTORC2 |
4 | RHEB | 295631 | 2% | 47% | 55 | Search RHEB | Search RHEB |
5 | RICTOR | 294979 | 2% | 47% | 54 | Search RICTOR | Search RICTOR |
6 | MTORC1 | 284266 | 4% | 23% | 108 | Search MTORC1 | Search MTORC1 |
7 | CCI 779 | 277099 | 1% | 78% | 31 | Search CCI+779 | Search CCI+779 |
8 | RAD001 | 259139 | 2% | 42% | 53 | Search RAD001 | Search RAD001 |
9 | MTOR INHIBITOR | 174963 | 4% | 16% | 96 | Search MTOR+INHIBITOR | Search MTOR+INHIBITOR |
10 | TEMSIROLIMUS | 169274 | 3% | 20% | 72 | Search TEMSIROLIMUS | Search TEMSIROLIMUS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |
rank | cluster_id2 | link |
---|---|---|
1 | 35540 | REDD1//RTP801//DDIT4 |
2 | 16537 | S6K2//RIBOSOMAL S6 KINASE 2 S6K2//P70 S6 KINASE |
3 | 20730 | BLSC//CELL ST S BIOL//GEROCONVERSION |
4 | 38283 | OXIDATIVE BALANCE SCORE//AFFLIATED NANJING CHILDRENS HOSP//AKT1 SNP RS2498804 |
5 | 4527 | PIK3CA//PI3K INHIBITOR//PI3K |
6 | 4504 | EIF4E//EIF4F//CAP ANALOG |
7 | 14707 | IMMUNOMETABOLISM//T CELL METABOLISM//VANDERBILT IMMUNOBIOL |
8 | 6660 | PDK1//AKT//AKT2 |
9 | 3427 | TUBEROUS SCLEROSIS//TUBEROUS SCLEROSIS COMPLEX//SUBEPENDYMAL GIANT CELL ASTROCYTOMA |
10 | 29252 | SESTRIN 2//SESTRIN//ANTICANC MOL ONCOL |